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Abstract
Effects of an alkylating anticancer drug, cyclophos-
phamide (Cp), on 23Na signal intensity (23Na SI) and
water apparent diffusion coefficient (ADC) were exam-
ined in subcutaneously – implanted radiation-induced
fibrosarcoma (RIF-1) tumors by in vivo 23Na and 1Hmag-
netic resonance imaging (MRI). MRI experiments were
performed on untreated control (n = 5) and Cp-treated
(n = 6) C3H mice, once before Cp injection (300 mg/kg)
then daily for 3 days after treatment. Tumor volumes
were significantly lower in treated animals 2 and 3 days
posttreatment. At the same time points, MRI experiments
showed an increase in both 23Na SI and water ADC in
treated tumors, whereas control tumors did not show
any significant changes. The correlation between 23Na SI
and water ADC changes was dramatically increased in
the Cp-treated group, suggesting that the observed in-
creases in 23Na SI and water ADC were caused by the
samemechanism.Histologic sections showeddecreased
cell density in the regions of increased 23Na and water
ADC SI. Destructive chemical analysis showed that Cp
treatment increased the relative extracellular space and
tumor [Na+]. We conclude that the changes in water ADC
and 23NaSIwere largelydue to an increase in extracellular
space. 23Na MRI and 1H water ADC measurements may
provide valuable noninvasive techniques for monitoring
chemotherapeutic responses.
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Introduction
An objective and accurate quantification of early treatment
response in tumors is highly desirable. Measurements of
parameters such as cellular energy status [1,2], tumor
lactate [3] and choline [4] levels, glycolytic rates [3,5], tis-
sue perfusion [6], and water diffusion coefficients [7,8] by
magnetic resonance (MR) techniques have been sug-
gested as noninvasive methods for monitoring response
to therapy. Commonly used anticancer therapies damage
and kill tumor cells, causing an increase in interstitial space
due to cell shrinkage (apoptosis) or rupture (necrosis) [9]. It
has been shown using isotope techniques that the alkylat-
ing anticancer drug, cyclophosphamide (Cp), significantly
increases the fraction of extracellular water [10]. Damage to
tissue microvasculature may also lead to vasogenic edema,
increasing the volume of extracellular water. Intracellular
water may also change because of alterations in membrane
permeability and ion transport processes across the cell mem-
brane. All of these changes may alter the mobility of water in
damaged tissues. The diffusion of tissue water in vivo can be
accurately and noninvasively estimated as an apparent diffu-
sion coefficient (ADC) by using diffusion-weighed 1H nuclear
magnetic resonance (NMR) [7,8,11,12]. Chenevert et al. [8]
have shown that water ADC is correlated with, and highly
sensitive to, changes in tumor cell density in histologic sec-
tions. Zhao et al. [7] showed a dose-dependent, reversible in-
crease in water ADC in radiation-induced fibrosarcoma (RIF-1)
tumors after Cp treatment, and the maximum water ADC in-
crease was observed 4 days after treatment.
Monitoring and imaging tissue Na+ by MR techniques
may also be useful for assessing response to therapy be-
cause of the biologic importance of sodium. Viable cells
maintain a much lower intracellular Na+ concentration ([Na+]i)
(10–30 mM) against a high extracellular Na+ concentra-
tion ([Na+]e) (f150 mM). This transmembrane sodium gra-
dient is maintained by the action of the Na+/K+ ATPase and
is used to drive several vital cellular processes through the
action of membrane-bound exchangers and cotransporters.
For instance, intracellular pH (pHi) is regulated, to a large
extent, by a Na+/H+ exchanger that transports excess H+ ions
out of the cell by allowing Na+ ions into the cell. Changes
in [Na+]i and pHi have also been suggested to be a part
of the signaling mechanism that initiates cell division and
proliferation [13–15].
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Because of its high tissue concentration, 100% natural
abundance, and short T1,
23Na is the second most sensi-
tive MR nucleus in tissues, with only 1H being more sensi-
tive. However, 23Na MR signal intensity is only 1/4000 that
of 1H. This is largely because the water proton concentra-
tion in tissue isf100 M, whereas the [Na+] is onlyf50 mM.
In addition, the relative NMR sensitivity of 23Na is 0.0925
compared to 1H [16]. Thus, the low signal-to-noise ratio
(SNR) of 23Na, which leads to relatively long imaging
times and/or poor spatial resolution, has restricted its use.
Interest in 23Na magnetic resonance imaging (MRI) has been
revitalized with the development of more effective data
acquisition schemes and hardware improvements, which
now allow quantitative imaging of tissue sodium in about
15 minutes [17–19].
23Na MRI signals from intracellular and extracellular
compartments are isochronous because Na+ exists in only
one chemical form in tissues. The tissue [Na+] is the volume-
weighted mean of the [Na+] in the intracellular and extra-
cellular spaces. Thus, an increase in extracellular space as a
result of therapy-induced cell loss should increase tissue
[Na+] ([Na+]tumor) and
23Na MRI signal intensity (23Na SI)
because [Na+]e is f10 times greater than [Na
+]i. The pos-
sible common mechanism for increases in water ADC and
tissue 23Na SI suggests that these parameters may show
similar changes during or after therapy. Therapy can also
alter [Na+] because of changes in [Na+]i as a result of altered
cellular physiology and metabolism before any cellular mem-
brane destruction. Effective therapy could increase or de-
crease [Na+]i depending on the effects of therapy on cellular
energy status and activity of membrane ion transport sys-
tems. Thus, 23Na MRI may provide additional information
than that available from water ADC measurements alone.
In the present study, we used 23Na and 1HMRI to examine
and correlate the changes in 23Na SI and water ADC in
response to the chemotherapeutic drug Cp using the RIF-1
tumor model. We also investigated the mechanism of the
observed changes in 23Na SI and water ADC through his-
tology and destructive chemical analysis.
Materials and Methods
Tumor Model
All animal studies were approved by the Indiana Univer-
sity Institutional Animal Care and Use Committee. RIF-1 tumor
cells were grown in monolayers using minimum essential
medium (MEM; Mediatech, Herdon, VA) supplemented with
10% fetal bovine serum, 10 mM HEPES, and 1% penicillin
under a 5% CO2 and 95% O2 atmosphere at 37jC. The tumor
cells were passaged between in vitro and in vivo states
according to the protocol of Twentyman et al. [20].
Male C3H/HeN mice (Harlan, Indianapolis, IN), approxi-
mately 6 weeks old and weighing 18 to 20 g, were inoculated
in the right or left flanks with a subcutaneous (sc) injection
of f2  106 cells in 0.10 to 0.15 ml volume of Hank’s
balanced salt solution. Animals were anesthetized with an
intraperitoneal (ip) injection of 50 mg/kg ketamine, 5 mg/kg
acepromazine, and 0.25 mg/kg atropine. The tumors were
allowed to grow for 2 to 3 weeks to a volume of 1.3 to
1.6 cm3 before performing the MRI experiments. Tumor
growth was monitored by caliper measurement for planning
the MRI experiments. Tumor volume was calculated from
three orthogonal diameters (x, y, and z) using the formula
(p/6)xyz. Ten tumor-bearing mice were treated with a single
dose of Cp (300 mg/kg, ip; Sigma-Aldrich, St. Louis, MO), six
of which were used for 1H and 23Na MRI experiments
and four were used for 23Na relaxation time measurements.
Nine animals served as untreated controls, five of which
were used for imaging experiments and the remaining ani-
mals were used for 23Na relaxation time measurements. The
MR experiments were performed prior to treatment with Cp
and on days 1, 2, and 3 after treatment. After the 3-day
posttherapy MR experiments, tumors were excised for his-
tology or destructive chemical analysis.
In Vivo MRI Experiments
All MR experiments were performed on a 9.4-T, 31-cm
horizontal bore system (Varian, Palo Alto, CA) equipped with
a 12-cm-diameter shielded gradient set capable of up to
40 G/cm in three directions. A loop-gap resonator (inner
diameter = 30 mm, depth = 25 mm) dual-tuned to 400 MHz
for 1H and to 106 MHz for 23Na was used. The animals
were anesthetized with 0.75% isoflurane delivered in medi-
cal air at 1 l/min using a mouse nose mask connected to a
gas anesthesia machine (Vetland, Louisville, KY). The tumor
and surrounding area were shaved to facilitate tumor mea-
surement and coil placement. The animal was positioned
on top of a custom-designed plastic cradle with the dual-
tuned loop-gap resonator attached to it. The tumor was
positioned inside the resonator, and the animal was held in
place with tape. A detachable cylindrical phantom (6.5 mm
diameter and 23 mm length) consisting of 154 mM NaCl
was also placed inside the resonator to serve as a 23Na MRI
signal intensity and water ADC standard. Warm air was
blown through the magnet bore to maintain the tempera-
ture in the space surrounding the animal at 26 to 28jC,
which was monitored with a fiber optic probe (FISO Tech-
nologies, Inc., Quebec, Canada). A rectal fiber optic tem-
perature probe was used to monitor the animal core body
temperature, which remained at 36 ± 1.4jC during the
MRI experiments (1–1.5 hours). The magnet was shimmed
to less than 100 Hz line width at half height of the 1H
water signal.
23Na MRI
Three-dimensional transaxial 23Na MR images of the
tumor were obtained using a gradient-echo imaging se-
quence. The following imaging parameters were used: 90
to 100 microseconds 90j excitation RF pulse, 50 milli-
seconds repetition time (TR), 10 milliseconds echo time
(TE), and 64  32  8 data points over a 40  40  36 mm
field of view (FOV). A relatively long TE was used to achieve
short sweep width (3700 Hz) and to optimize the SNR in
23Na images. The noise in an image is directly proportional
to the square root of the sweep width; thus, decreasing the
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sweep width should increase the image SNR. However,
decreasing the sweep width increases the acquisition time
and TE, resulting in signal loss due to T2* relaxation. The
optimum TE and sweep width that give the maximum SNR
were calculated as described by Vinitski et al. [21] from
the relaxation characteristics of the tumor 23Na signal and
other imaging parameters used in the study. In addition, the
weighted signal summation (WSS) technique was employed
in the two phase-encoding directions to further improve
SNR [22]. In the WSS technique, the numbers of signal
transients summed at different phase-encoding steps are
varied such that WSS produces similar signal conditioning
effects as produced by apodization with a Gaussian function.
This method of data collection increases SNR by f50%
compared to performing apodization after data collection
[22]. A maximum of 128 and an average of 55 signal tran-
sients were collected for the phase-encoding steps. Total
data collection time for the 3D 23Na image was 14 minutes.
The time domain data were zero-filled once in both phase-
encoding directions (giving a 64  64  16 data matrix) and
Fourier-transformed.
1H MRI
Water ADC in the tumor was measured using a multi-
slice diffusion-weighted imaging (DWI) sequence. The fol-
lowing imaging parameters were used: 1100 milliseconds
TR, 60 milliseconds TE, 256  128 data points over a 40 
40 FOV, 2.0 mm slice thickness, and 0.6 mm slice gap. DWI
1H images were collected using four interleaved b-factors
(b = 0, 236, 945, and 1,679 sec/mm2). These b-values are
similar to the values used in other publications [8,19,23].
Duration of diffusion gradient pulses was 10 milliseconds,
and the delay between the gradient pulses was 40 milli-
seconds. The orientation of the diffusion gradients was in the
read-out direction (y ). Total imaging time was 19minutes. 1H
images and water ADC maps were reconstructed using the
Image Browser software provided by Varian. The tumor
volume and average water ADC were determined over a
3D volume of interest for each temporal measurement.
23Na Relaxation Time Measurements
Because the TE used in the
23Na MRI experiments
was relatively long, 23Na relaxation times for control and
Cp-treated tumors were measured. A 10-mm-diameter sur-
face coil was used to measure T1 and T2 to avoid signal
contamination from normal tissues surrounding the tumor.
23Na T1 was measured using a pulse-burst saturation re-
covery pulse sequence consisting of 50 saturation pulses
followed by an incremental delay (15 values ranging from
1 to 256 milliseconds) and a 90j observed pulse and acqui-
sition with Cyclops phase cycling. The instrument dead
time was set to 10 microseconds for all relaxation experi-
ments. 23Na T2f and T2s were measured using a Hahn spin-
echo sequence consisting of a composite 180j pulse [24].
The TE was varied from 0.05 to 40 milliseconds. The in-
strument dead time of 10 microseconds was included as a
part of the TE. One thousand twenty-four complex data
points were collected over a sweep width of 3000 Hz, and
either 128 or 256 transients were acquired at each relax-
ation delay for both T1 and T2 experiments. The relaxation
times were computed by fitting the signal areas to both a
monoexponential function and a biexponential function. The
experimental conditions, including tumor volume, type of
anesthesia, and drug treatment, were identical in both the
23Na MRI and relaxation time experiments.
Histology
Following the last 1H and 23Na MRI experiments 3 days
after Cp injection, the animals were sacrificed by an over-
dose of ketamine injected intraperitoneally. The anterior part
of the tumor was marked with a permanent marker. The
tumor and surrounding skin were detached from the animal
body, fixed in 25% zinc–formalin solution (Anatech, Battle
Creek, MI), and then embedded in paraffin. The histologic
sections of the tumor were cut perpendicular to the body wall
along the same plane as the MR images. Tissue sections
were obtained at 5 mm thickness and stained with hema-
toxylin and eosin (H&E) to identify regions with different cell
densities. Three histology slices, from the anterior, middle,
and posterior regions of each tumor, were compared with
water ADC maps and 23Na MRI. During the MRI experi-
ments, special care was taken in positioning the tumor
exactly in the middle of the magnet with the help of a read-
out gradient along the z-axis. Thus, we assume that the
hitologic slices from the middle region correspond to the
middle slice in the MR images. There may be a slight mis-
match in orientation between the two images, but it should
not affect the comparison drastically because the 1H and
23Na MRI slices were relatively thick (f2 mm) compared to
the histologic slices (5 mm). The histologic regions with low
cell density that contain relatively few intact nuclei and
liquefied/caseous materials were designated as ‘‘necrotic’’
[25,26]. These regions can be differentiated from regions
of higher cell density (‘‘viable’’ regions) on lower-resolution
images. Digital micrographs were obtained with a Nicon
Coolpix 4500 (Nicon, Inc., Torrance, CA) and histologic slices
were analyzed withMicrostar IV (IMEB, Inc., Columbus, OH).
Destructive Chemical Analysis
The effects of Cp treatment on relative extracellular
space (rECS) and [Na+]tumor were measured by destructive
chemical analysis following the last 23Na relaxation time
measurement 3 days after Cp injection. The animals were
kept under isoflurane gas anesthesia and an 80 mM solution
of cobalt ethylenediaminetetraacetate (CoEDTA; Sigma-
Aldrich), an extracellular space marker, was infused through
a catheter in the tail vein at 0.2 ml/hr (6 min), 0.4 ml/hr
(6 min), 0.6 ml/hr (6 min), 0.8 ml/hr (6 min), and 0.5 ml/hr
(60 min). As shown earlier [27,28], a similar infusion pro-
tocol allowed equilibration of CoEDTA, throughout all extra-
cellular space in rat tissues, including the tumor. A blood
sample (f0.5 ml) was withdrawn from the heart/chest
area. The tumor was then quickly excised and all skin and
muscles surrounding the tumor were removed. The tumor
was immediately freeze-clamped using aluminum tongs
precooled in liquid nitrogen, weighed, dried overnight at
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60jC, and reweighed to establish the relative dry-to-wet
weight ratio (rDW). The blood and tumor samples were
prepared for analysis of Co3+ and Na+ by inductively coupled
plasma (ICP) spectrometry using standard procedure [27].
The dried tissue samples were digested in 2 ml of concen-
trated nitric acid overnight in a water-heating bath held at
50jC, and blood samples were centrifuged to remove the
erythrocytes from the plasma. The samples were then di-
luted in deionized water, and [Na+] and [Co3+] were mea-
sured by ICP at 330.232 and 228.616 nm, respectively. The





where [Co3+]tumor and [Co
3+]plasma are the concentrations
of Co3+ in the tumor and blood plasma, respectively. This
method assumes that the [Co3+] in the extracellular space
of the tumor is equal to [Co3+]plasma.
Statistical Analysis
All data are presented as the mean ± SEM. Sta-
tistical analyses of the data were performed by ANOVA
(Statistica/v. 5.1 program). P V .05 was used to define
statistical significance.
Results
Effect of Cp on Tumor Growth
The mean tumor volumes of control and treated mice
measured from 1H MRI are shown in Figure 1A. Before
treatment, both groups had similar tumor volumes (1.3 ±
0.2 cm3 for control group, 1.7 ± 0.2 cm3 for treated group;
P = .18). In Cp-treated animals, the mean tumor volume
decreased to 1.3 ± 0.2 cm3 (P V .05 vs pretreatment) on
day 2 and to 1.1 ± 0.2 cm3 (P V .05 vs pretreatment) on
day 3 after treatment. The mean tumor volume in control
animals (1.7 ± 0.2 cm3 ) was greater (P V .05) than the
baseline volume 3 days after treatment. The mean tumor
volume in treated animals was significantly lower than in
control animals 3 days after treatment (P V .01).
ADC of Water
The mean water ADC values in control and treated tu-
mors prior to and after Cp injection are shown in Figure 1B.
Water ADC was similar in control and treated groups (4.4 ±
0.2 104 and 4.9 ± 0.2 104 mm2/sec, respectively) prior
to treatment. In the control group, the mean water ADC
did not change significantly over the 3 days, whereas in the
treated group, water ADC increased significantly 2 and
3 days after Cp injection (5.8 ± 0.3  104 and 7.3 ± 0.4 
104 mm2/sec, respectively) compared to baseline (P V .05)
and control tumors (P V .01) for both time points.
Examples of a pixel-by-pixel water ADC map for a con-
trol tumor and a treated tumor before and 1, 2, and 3 days
after Cp injection are shown in Figure 2. The water ADC
values before Cp treatment (day 0) were 4.9  104 and
5.4  104 mm2/sec in the control and treated tumors, res-
pectively. After Cp injection, water ADC increased progres-
sively to 5.9 104 , 6.5  104 , and 7.6  104 mm2/sec on
days 1, 2, and 3, respectively. The water ADC increase was
observed not only in tumor regions with low cell density (bright
region in the lower right quadrant of the tumor in Figure 2)
but throughout the whole tumor. In the untreated tumor,
water ADC decreased slightly and was 4.5  104 mm2/sec
on day 3.
23Na MRI and Magnetic Resonance Spectroscopy (MRS)
Figure 2 also shows 23Na MR images of the same control
and treated tumors before and 1, 2, and 3 days after Cp
injection. Similar to the water ADC maps, 23Na MRI showed
heterogeneous signal intensity in both tumors, reflecting
Figure 1. Effects of Cp therapy (300 mg/kg, ip) on tumor volume (A), water
ADC (B), and 23Na SI from the tumor relative to the reference (Na+tumor/
Na+ref) (C) in sc implanted RIF-1 tumors. Tumor volumes were measured
from 1H MRI. Water ADC and relative 23Na SI changes are the mean from the
whole tumor. Cp treatment caused a significant decrease in tumor volume
and significant increases in water ADC and 23Na SI 2 and 3 days posttherapy.
Significance: PV .05 (*– versus before treatment), PV .01 (** – control versus
Cp-treated). Data are presented as mean ± SEM.
23Na MRI of Chemotherapeutic Response Babsky et al. 661
Neoplasia . Vol. 7, No. 7, 2005
the inherent heterogeneity in the tumor microenvironment. In
the control tumor, the 23Na signal was relatively stable and
even slightly decreased by day 3. However, in the treated
tumor, the 23Na SI increased steadily (44% by day 3 after
Cp injection). The most dramatic increase in 23Na signal
was observed in the region with low cell density, but an in-
crease in signal intensity was detected throughout the tu-
mor. Similar increases in 23Na SI were observed in all the
treated tumors.
The changes in tumor 23Na SI with respect to the refer-
ence signal intensity for control and treated groups prior to
and after Cp injection are shown in Figure 1C. The mean
of tumor to reference 23Na SI ratio was similar for the con-
trol and Cp-treated groups at baseline: 0.48 ± 0.06 and
0.51 ± 0.04, respectively. The ratio did not change signifi-
cantly for the control group. The treated group showed a
progressive increase in tumor 23Na SI. The tumor to refer-
ence 23Na SI ratio was 0.54 ± 0.03 on day 2 and 0.58 ± 0.04
on day 3 after Cp injection (P V .05 compared to the same
time points for control).
The values of T1, T2s, and T2f, and the relative contribution
of T2s to the observed
23Na signal for control and Cp-treated
tumors are listed in Table 1. There were no significant dif-
ferences in the relaxation times or the relative contribution
of the fast and slow relaxation components between control
and treated tumors at any time point (P z .1). These relax-
ation parameters were measured using a separate group
of animals than that used in the MRI experiments for two
reasons. First, the imaging experiments took over an hour
and we did not want to keep the animals under anesthesia
and strained conditions any longer. Second, a surface coil
was used for the relaxation time measurements to avoid
contamination from healthy tissues near the tumor. The
experimental conditions, including tumor volume, type of
anesthesia, and drug treatment, were identical in both the
23Na MRI and relaxation time experiments.
Correlation between Water ADC and 23Na MRI
Spatial correlation between water ADC and 23Na SI for
the control and treated tumors is apparent in the images
shown in Figure 2. The regions with high water ADC are also
hyperintense in 23Na MRI. Figure 3 shows a plot of mean
water ADC and mean 23Na SI for control and treated tumors.
Each data point represents all the tumors at a specific day.
Although the correlation between water ADC and [Na+]tumor
Figure 2. Water ADC maps and 23Na MR images of representative control and Cp-treated RIF-1 tumors before and 1, 2, and 3 days after Cp treatment. Water
ADC and 23Na signal intensity increased with time after Cp treatment. A vial filled with a 154-mM NaCl solution was placed near the tumor as a reference.
Table 1. Experimental Relaxation Times of 23Na Signal from Control and
Cp-Treated Tumors Before and After Therapy.
Day 0 Day 1 Day 2 Day 3
T1 (msec)
Control 43.1 ± 3.6 40.6 ± 1.4 42.8 ± 3.5 43.6 ± 1.1
Cp-treated 42.0 ± 1.8 38.9 ± 0.4 43.1 ± 0.7 44.7 ± 1.7
T2s (msec)
Control 22.7 ± 0.4 22.5 ± 0.6 22.0 ± 1.1 21.1 ± 0.6
Cp-treated 25.4 ± 1.7 21.6 ± 1.1 24.8 ± 0.5 26.1 ± 0.6
T2f (msec)
Control 3.1 ± 0.2 3.2 ± 0.3 2.8 ± 0.1 2.8 ± 0.1
Cp-treated 3.7 ± 0.7 2.8 ± 0.2 3.5 ± 0.3 3.3 ± 0.2
Relative contribution from T2f
Control 0.52 ± 0.01 0.50 ± 0.01 0.53 ± 0.01 0.56 ± 0.03
Cp-treated 0.43 ± 0.05 0.47 ± 0.02 0.49 ± 0.01 0.48 ± 0.01
Values are reported as mean ± SEM (n = 4 for each group). No significant
differences were found between control and Cp-treated tumors at any time
point studied.
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was poor in the control tumors, the correlation was signifi-
cant (R2 = 0.97) in Cp-treated tumors.
Histology
H&E–stained sections (low and high resolution, 20) of
a control and a Cp-treated tumor and the corresponding
water ADC maps and 23Na images are shown in Figure 4.
MRI maps and histologic segments have a slice thickness
of 2 mm and 5 mm, respectively. Viable tissue is visible in
the low-resolution histologic segments as the darker pur-
ple color, and necrotic areas are visible as the brighter pink
areas. There is reasonable agreement between the MR
images and the histologic sections in both tumors. For ex-
ample, in the Cp-treated tumor, the region with the highest
Na+ signal intensity corresponded to the histologic region
with the lowest cell density (histologic section D), and the
region with the lowest Na+ signal intensity corresponded to
the most viable histologic section (C). Comparison of histo-
logic sections of control and Cp-treated tumors shows that
both high and low cell density regions of treated tumors
(C and D) contain fewer cells than control tumors (A and B).
The necrotic regions with low cell density of both control
and Cp-treated tumors also contained high extracellular
collagen, a characteristic of fibrosarcoma.
Destructive Chemical Analysis
The ICP data for tissue compartmentalization and Na+
content for control and Cp-treated tumors 3 days after treat-
ment are shown in Table 2. In Cp-treated tumors, rDW
was significantly lower (P V .05) and rECS was significantly
higher (P V .05) compared to the untreated tumors. The
[Na+]tumor was 29.4% higher in Cp-treated tumors than in
control tumors (58 ± 10 and 45 ± 7mM, respectively;PV .05).
Discussion
In this study, we examined the effects of Cp treatment
on 23Na MRI as a noninvasive marker of tumor response
to cancer chemotherapy and compared these Na+ signal
changes with water ADC measured by diffusion-weighted 1H
MRI. The Cp injection caused a significant reduction in tumor
volume 2 and 3 days posttreatment. Poptani et al. [5] and
Zhao et al. [7] have shown similar changes in RIF-1 tumor
volumes after Cp treatment. Cp itself is a prodrug, which
is oxidized in the liver to 4-hydroxycyclophosphamide and
subsequently converted to nitrogen mustard and other
metabolites. In RIF-1 tumors, Cp metabolites do not directly
disrupt cell metabolism, but rather these metabolites alkylate
DNA and proteins. It has been shown [29,30] that for RIF-1
and other animal tumors, Cp causes cell death by stimulat-
ing apoptosis, as evidenced by the induction of plasma
membrane blebbing, DNA fragmentation, and cleavage of
the caspase 3 and caspase 7 substrate poly(ADP-ribose)
polymerase. These genetic and cellular transformations lead
to some metabolic effects of Cp, such as a decrease in
mitotic activity [5,31], an increase in water diffusion, and an
Figure 3. Correlation between mean water ADC and 23Na SI in untreated (.)
and Cp-treated (5) RIF-1 tumors. Each data point represents all the tumors
at a specific day. The R2 coefficient for Cp-treated tumors was more than
three times higher than for the untreated tumors.
Figure 4. H&E–stained histologic slices, water ADC maps, and 23Na MRI images of representative control and Cp-treated RIF-1 tumors 3 days after treatment.
Histologic and MRI slices from the middle part of the tumors are presented. Arrows point to the regions identified as ‘‘viable’’ (A and C) and ‘‘necrotic’’ (B and D) in
both tumors. These regions are presented as high-resolution (original magnification, 20) histologic images. The regions of tumors with higher 23Na signal and
water ADC mostly correspond to the histologic regions with fewer cells.
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increase in aerobic metabolism that decreases the glycolytic
rate in RIF-1 cells [5].
We have shown that treatment of RIF-1 tumors with
300 mg/kg Cp significantly increased water ADC 2 and
3 days posttreatment. Braunschweiger [10] and Makin [30]
have shown that Cp-induced changes in tissue microvas-
culature and apoptotic/necrotic damage of tumor cells lead
to large reductions in cell volume and increases in the
volume of extracellular water. These changes may increase
the mobility of water in the damaged tissue and lead to an
increase in water ADC in Cp-treated tumors, as we have
shown. Our ICP and histologic results also support this hypo-
thesis. The ICP data show a significant increase in rECS,
whereas the histologic data show a decrease in the number
of cells and an increase in extracellular space (Figure 3). It
has been shown previously that the increase in water ADC
correlates with both the increase in tumor necrotic fraction
in RIF-1 tumors [25] and the decrease in tumor cell density
in 9L glioma [8].
The b-values used in this work are similar to the values
used in other publications [8,19,23]. We did not detect
any nonexponential behavior with these b-values. Such
behavior could be detected by using higher b-values and
a larger number of data points. However, we did not at-
tempt this because it would require long data collection
times, especially at high b-values where SNR is low. We
were simply interested in using water ADC as a therapy
response parameter.
The increase in extracellular space following therapy
can cause not only an increase in water ADC but also an
increase in [Na+]tumor, as [Na
+]e is 10 to 15 times higher
than [Na+]i. We found that, on average, both
23Na SI and
water ADC increased throughout the tumor after Cp treat-
ment. The increase in 23Na SI after chemotherapy could
be because of an increase in [Na+]tumor or a change in
23Na relaxation times. Our data showed that Cp treatment
or untreated growth of RIF-1 tumors did not significantly
change the T1, T2s, and T2f values, or the relative contribu-
tions of T2s and T2f (Table 1). These results suggest that
the observed increase in 23Na MRI signal intensity after Cp
treatment was due to increases in [Na+]tumor caused by Cp
treatment. Our ICP data confirmed that in Cp-treated tumors,
[Na+]tumor is significantly increased 3 days after treatment
(45 ± 7 mM, control; 58 ± 10 mM, Cp-treated) (Table 2). The
value of the Cp-induced increase in [Na+]tumor was compa-
rable for both MRI (36.8%) and ICP (29.4%) methods.
Although the extracellular space increases after therapy,
we believe that [Na+]e remains constant. [Na
+]e can be
maintained constantly by the transport of Na+ from the vas-
cular and/or interstitial space of the nearby uncompromised
tissue even in hypoxic or necrotic regions. Moreover, pre-
vious 1H MRI studies show that tumor perfusion is increased
after therapy [5]. Thus, transport of Na+ from the vascular
space can maintain [Na+]e, and an increase in extracellular
space results in increased [Na+]tumor after therapy.
There was a good correlation between 23Na SI and
water ADC in the Cp-treated tumors (Figure 3). One pos-
sible reason for this effect may be that [Na+]tumor increases
with increased extracellular space because of cells lost
through apoptosis and/or necrosis. Schepkin et al. [19]
also showed that a large increase in 23Na MRI signal
intensity occurred 7 to 9 days following treatment with
1,3-bis (2-chlorethyl)-1-nitrosourea (BCNU; another chemo-
therapeutic alkylating agent), which correlated to the period of
the greatest chemotherapy-induced cellular necrosis based
on water ADC changes and histopathology.
Changes in [Na+]tumor and water ADC may be related,
but 23Na images may provide more functional information
because therapy can also alter [Na+]i, which depends on the
cellular energy status and activity of ion transport processes.
Many reports show that radiotherapy and most chemo-
therapies (including treatment of RIF-1 tumors with Cp)
cause increased ATP levels and decreased Pi in experimen-
tal tumors [1,32,33]. This effect is thought to be a result of
increased perfusion and oxygenation of the tumor [3,5,34].
The improved cellular energy status should aid in maintain-
ing low [Na+]i because of the high activity of the Na
+ /K+
ATPase. However, a decrease in [Na+]i following effective
therapy may not be a general phenomenon. An ischemia-like
response of tumors to therapy (decreased ATP level) and/or
partial destruction of the cellular membrane or membrane-
embedded proteins can produce an increase in [Na+]i. For
example, Ben-Yoseph and Ross [35] demonstrated that
treatment of sc implanted 9L glioma with polyethylene glycol–
stabilized glucose oxidase results in a 96% reduction in the
ATP/Pi and a 0.72-U decline in pHi. In this case, [Na
+]i should
increase. Thus, because of the sensitivity of 23Na MRI to
cellular function, it may provide additional information than
that available from water ADC measurements alone.
Differences in tumormodel and treatment can play important
roles in tumor Na+ response. In contrast to Schepkin et al. [19]
and the results presented here, Winter et al. [27] show that
BCNU therapy of subcutaneously implanted 9L glioma
results in decreased SQ and TQF 23Na SI compared to un-
treated control tumors. This difference in therapy response
could be because of differences in rECS changes in the
different tumor models. Winter et al. [27] did not observe any
difference in rECS between treated and untreated tumors but
showed improved cellular energetics and increased pHi in sc
implanted 9L glioma after BCNU therapy. These metabolic
changes could decrease intracellular and total tissue Na+.
We have performed some initial 23Na MRI and water ADC
measurements on subcutaneously implanted 9L glioma with
BCNU therapy. Our preliminary data suggest that both tissue
Table 2. Tissue Compartmentalization and Na+ Content of Control and Cp-
Treated RIF-1 Tumors 3 Days After Therapy as Measured by Destructive
Chemical Analysis.
rDW rECS [Na+]tumor (mM)
Control 0.21 ± 0.01 0.26 ± 0.04 45 ± 7
Cp-treated 0.16 ± 0.01* 0.46 ± 0.08* 58 ± 10*
Values are reported as mean ± SEM (n = 7 for control and n = 5 for Cp-
treated group).
*Significance: P V .05 (control vs. Cp-treated).
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Na+ and water ADC are lower in BCNU-treated tumors com-
pared to untreated controls.
Usually both water ADC maps and 23Na images had
some verifiable heterogeneity in subcutaneously implanted
RIF-1 tumors. In some regions, when 23Na SI was high,
water ADC was not dramatically increased. A possible
reason for this discrepancy may be that 23Na SI can also
increase as a result of increase in [Na+]i. Movement of Na
+
and water into the cells can cause a decrease in water
ADC because of a high macromolecule concentration inside
the cells. An increase in extracellular space increases both
water ADC and [Na+]tumor, whereas cytotoxic edema de-
creases water ADC but increases [Na+]tumor. Thus, a com-
bination of both increased extracellular space and cytotoxic
edema can cause the observed discrepancy between water
ADC and 23Na SI.
Conclusions
In vivo MRI experiments showed that both 23Na SI and
water ADC increase 2 days after chemotherapy of sub-
cutaneously implanted RIF-1 tumors with Cp. These effects
were largely due to an increase in extracellular space as
shown by histology and destructive chemical analysis. The
increase in 23Na MRI signal intensity after Cp treatment
observed in this study may prove useful for detecting early
therapy response and may support the mechanism for water
ADC changes.
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